Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.9850 (-3.56%) ($7.9850 - $7.9850) on Thu. May. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 41 | Latest Price | $7.9850(-3.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLRE(28%) BND(27%) ARKG(26%) SDY(25%) VYM(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.34% in a week (0% probabilities). VIXM(-25%) VXX(-24%) TLT(-13%) VCIT(-11%) SHY(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.32 | 5 Day Moving Average | $8.39(-4.83%) | 10 Day Moving Average | $8.44(-5.39%) | 20 Day Moving Average | $8.32(-4.03%) | To recent high | -11.7% | To recent low | 8.3% | Market Cap | $1.409b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |